The Russell Varian Prize was an international scientific prize awarded for a single, high-impact and innovative contribution in the field of nuclear magnetic resonance (NMR), that laid the foundation for the development of new technologies in the field.[1] It honored the memory of Russell Varian, the pioneer behind the creation of the first commercial NMR spectrometer and the co-founder, in 1948, of Varian Associates, one of the first high-tech companies in Silicon Valley.[2] The prize carried a monetary award of €15,000 and it was awarded annually between the years 2002 and 2015 (except for 2003) by a committee of experts in the field.[1] The award ceremony alternated between the European Magnetic Resonance (EUROMAR) Conference and the International Council on Magnetic Resonance in Biological Systems (ICMRBS) Conference.[1] Originally, the prize was sponsored by Varian, Inc. and later by Agilent Technologies,[3] after the latter acquired Varian, Inc. in 2010.[4] The prize was discontinued in 2016 after Agilent Technologies closed its NMR division.[5]
^Morris, G.A. (1979). "Enhancement of Nuclear Magnetic Resonance Signals by Polarization Transfer". Journal of the American Chemical Society. 101 (3): 760–762. doi:10.1021/ja00497a058.
^Freeman, R.; Anderson, W.A. (1962). "Use of Weak Perturbing Radio-Frequency Fields in Nuclear Magnetic Double Resonance". Journal of Chemical Physics. 37 (9): 2053–2074. Bibcode:1962JChPh..37.2053F. doi:10.1063/1.1733426.